期刊文献+

银杏达莫注射液治疗糖尿病周围神经病变临床观察 被引量:3

Clinical analysis for Ginkgo-Dipyidamolum in treating patients with diabetic peripheral nerve diseases
在线阅读 下载PDF
导出
摘要 目的观察银杏达莫注射液治疗糖尿病周围神经病的疗效。方法将57例周围神经病变患者随机分成2组,对照组采用周围神经病变的常规治疗方法,治疗组在对照组用药基础上加用银杏达莫注射液,每日静滴20ml治疗3周,并在治疗12周后观察患者症状和体征、血糖情况。结果治疗12周后,银杏达莫注射液治疗组对改善周围神经病变患者的肢体疼痛、麻木、发凉、感觉异常和/或减退等临床症状的总有效率为78.57%,较对照组51.72%,有显著性差异(P<0.01)。结论银杏达莫注射液对改善周围神经病变患者的临床症状有明显疗效,是治疗周围神经病变的有效方法之一。 Objective To evaluate the therapeutic effect of Ginkgo - Dipyidamolum on the patients with diabetic peripheral nerve diseases (DPND). Methods Fifty - Seven patients with DPND were randomly divided into two groups. 29 patients in group A (control group) were treated by routine therapy;28 patients in group B (treatment group), on the treatment basis of group A, were treated with Ginkgo -Dipyidamolum by intravenous infusions, 20 ml daily for 3 weeks. The symptoms and physical signs of patients, were observed after 12 weeks. Results The total effective rate in improving the clinical symptoms was 78.57% in group B and 51.72% in group A. There was a significant difference between two groups(P 〈 0.01 ). Conclusions Ginkgo -Dipyidamolum is effective in improving the clinical symptoms of DPND patients.
作者 吴洲 武风云
出处 《医学信息(手术学分册)》 2007年第4期337-338,共2页 Medical Information Operations Sciences Fascicule
关键词 糖尿病周围神经病 银杏达莫 diabetic peripheral nerve disease Ginkgo - Dipyidamolum
  • 相关文献

参考文献5

二级参考文献22

  • 1耿秀芳,徐瑗民,刘同美,郭淑睿,钟桂美,李桂芝.银杏叶总黄酮的抗自由基作用[J].潍坊医学院学报,1993,15(1):10-12. 被引量:5
  • 2严萍萍,戴瑞鸿.内皮素与冠心病[J].心血管病学进展,1993,14(6):330-333. 被引量:4
  • 3钟南山,徐军.哮喘发病机制及诊断新进展(现代呼吸系疾病系统讲座第五讲)[J].中华结核和呼吸杂志,1995,18(3):136-139. 被引量:168
  • 4耿秀芳,孟祥国,栾美英,李乃敏,孙风祥.银杏叶黄酮扩血管机理的探讨[J].中医药研究,1996,12(1):55-56. 被引量:33
  • 5各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33091
  • 6Obrosova I G, Fathallah L, Stevens M J. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy[J]. Exp Neurol, 2001,172:211-219.
  • 7Elias K A, Cronint M J, Stewart T A, et al. Peripheral neuropathy in transgenic diabetic mice:restoration of C-fiber function with human recombinant nerve growth factor[ J].Diabetes, 1998,47 : 1637-1642.
  • 8Apfel S C , Kessler S A , Adomato B T , et al. Recombinant human nerve growth factor in the treatment of diabetic peripheral neuropathy [ J ]. Neurology, 1998,51 : 695-702.
  • 9Thrailkill K M. Insulin-like growth factor-I in diabetes mellitus : its physiology, metabolic effects, and potential clinical utility [ J ] . Diabetes Technol Ther, 2000,2 : 69-80.
  • 10Isner J M, Ropper A, Hirst K. VEGF gene transfer for diabetic neuropathy [J]. Hum Gene Ther, 2001, 12: 1593-1594.

共引文献67

同被引文献29

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部